What's new

Referral: Finasteride- and dutasteride-containing medicinal products, finasteride,dutasteride Article 31 referrals CMDh final position, 20/06/2025

Referral: Finasteride- and dutasteride-containing medicinal products, finasteride,dutasteride Article 31 referrals CMDh final position, 20/06/2025

Jun 20, 2025 - 12:25
 0
Referral: Finasteride- and dutasteride-containing medicinal products, finasteride,dutasteride Article 31 referrals CMDh final position, 20/06/2025
Referral: Finasteride- and dutasteride-containing medicinal products, finasteride,dutasteride Article 31 referrals CMDh final position, 20/06/2025
Read More

Tags:

Previous Article

Opinion on medicine for use outside EU: Dapivirine Vaginal Ring 25 mg, dapivirin...

Next Article

Human medicines European public assessment report (EPAR): Zemcelpro, allogeneic ...

Related Posts

Human medicines European public assessment report (EPAR): Tysabri, natalizumab, Date of authorisation: 27/06/2006, Revision: 48, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 19, 2025  0

Human medicines European public assessment report (EPAR): Eltrombopag Accord, eltrombopag, Date of authorisation: 28/03/2025, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

May 20, 2025  0

2024 annual report of the European Medicines Agency

Jun 10, 2025  0